Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment

Jayant S. Vaidya (Lead / Corresponding author), Max Bulsara, Michael Baum, Jeffrey S. Tobias, TARGIT-A trial authors

    Research output: Contribution to journalComment/debatepeer-review

    1 Downloads (Pure)

    Abstract

    In the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.

    Original languageEnglish
    Number of pages6
    JournalBritish Journal of Cancer
    Early online date2 Feb 2021
    DOIs
    Publication statusE-pub ahead of print - 2 Feb 2021

    Fingerprint Dive into the research topics of 'Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment'. Together they form a unique fingerprint.

    Cite this